BioLineRx (BLRX) Tops Q3 EPS by 6c

BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion